Treatment of Lymphoid Malignancies with Non-myeloablative Stem Cell Transplantation

References

• van Besien, K., Sobocinski, K.A., Rowlings, P.A., Murphy, S.C., Armitage, JD., Bishop, M.R., Chaekal, O.-K., Gale, R.P., Klein, J.P., Lazarus, H.M., McCarthy, Pi., Raemaekers, J.J.M.M., Reiffers, J., Phillips, G.L., Schattenberg, A.V.M.B., Verdonck, L.F., Vose, J.M. and Horowitz, M.M. (1998) "Allogeneic bone marrow transplantation for low-grade lymphoma", Blood 92, 1832–1836.
   PubMed Web of Science ®Google Scholar
• Dhedin, N., Giraudier, S., Gaulard, P., Esperou, H., Ifrah, N., Michallet, M., Milpied, N., Rio, B., Cahn, J.Y., Molina, L., Laporte, J.L., Guilhot, F. and Kuentz, M. (1999) "Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lym-phoma): a series of 73 patients from the SFGM database", Br. J. Haematol. 107, 154–161.
   PubMed Web of Science ®Google Scholar
• Toze, C.L., Shepherd, J.D., Connors, J.M., Voss, N.J., Gascoyne, R.D., Hogge, D.E., Klingemann, H.-G., Nantel, S.H., Nevill, T.J., Phillips, G.L., Reece, D.E., Sutherland, H.J. and Barnett, M.J. (2000) "Allogeneic bone marrow transplan-tation for low-grade lymphoma and chronic lymphocytic leukemia", Bone Marrow Transplant. 25, 605–612.
   PubMed Web of Science ®Google Scholar
• Gahrton, G., Tura, S., Ljungman, P, Belanger, C., Brandt, L., Cavo, M., Facon, T., Granena, A., Gore, M., Gratwohl, A., Lowenberg, B., Nikoskelainen, J., Reiffers, J.J., Samson, D., Verdonck, L. and Volin, L. (1991) "Allogeneic bone marrow transplantation in multiple myeloma", N. Engl. J. Med. 325, 1267–1273.
   PubMed Web of Science ®Google Scholar
• Reece, D.E., Shepherd, J.D., Klingemarm, H.G., Sutherland, H.J., Nantel, S.H., Barnett, M.J., Spinelli, J.J. and Phillips, G.L. (1995) "Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation", Bone Marrow Transplant. 15, 117–123.
   PubMed Web of Science ®Google Scholar
• Ratanatharathorn, V., Uberti, J., Karanes, C., Abella, E., Lum, L.G., Momin, E, Cummings, G. and Sensenbrenner, L.L. (1994) "Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma", Blood 84(4), 1050–1055.
   PubMed Web of Science ®Google Scholar
• Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Körbling, M., Keating, M., Kantarjian, H. and Champlin, R. (1997) "Engraftment of allogeneic hematopoie-tic progenitor cells with purine analog-containing chemother-apy: harnessing graft-versus-leukemia without myeloablative therapy", Blood 89, 4531–4536.
   PubMed Web of Science ®Google Scholar
• Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. and Or, R. (1998) "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases", Blood 91, 756–763.
   PubMed Web of Science ®Google Scholar
• Childs, R., Clave, E., Contentin, N., Jayasekera, D., Hensel, N., Leitman, S., Read, E.J., Carter, C., Bahceci, E., Young, N.S. and Barrett, A.J. (1999) "Engraftment kinetics after nonmyeloa-blative allogeneic peripheral blood stem cell transplantation: full donor T cell chimerism precedes alloimmune responses", Blood 94, 3234–3241.
   PubMed Web of Science ®Google Scholar
• Stewart, FM., Zhong, S., Wuu, J., Hsieh, C., Nilsson, S.K. and Quesenberry, P.J. (1998) "Lymphohematopoietic engraftment in minimally myeloablated hosts", Blood 91(10), 3681–3687.
   PubMed Web of Science ®Google Scholar
• Storb, R., Yu, C., Barnett, T., Wagner, J.L., Joachim, D.H., Nash, R.A., Kiem, H.-P., McSweeney, P., Seidel, K., Georges, G. and Maciej Zaucha, J. (1999) "Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs give lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation", Blood 94, 1131–1136.
   PubMed Web of Science ®Google Scholar
• Weiden, Pi., Sullivan, K.M., Flournoy, N., Storb, R. and Thomas, E.D. (1981) "Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation", N. Engl. J. Med. 304(25), 1529–1533.
   PubMed Web of Science ®Google Scholar
• Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C. and Speck, B. (1990) "Graft-versus-leukemia reactions after bone marrow transplantation", Blood 75, 555–562.
   PubMed Web of Science ®Google Scholar
• Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L. and Niederwieser, D. (1995) "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European group for blood and marrow transplan-tation working party chronic leukaemia [see comments]", Blood 86, 2041–2050.
   PubMed Web of Science ®Google Scholar
• MacKinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, E, Castro-Malaspina, H., Childs, B.H., Gillio, A.P. and Kernan, N.A. (1995) "Adoptive immunother-apy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease", Blood 86, 1261— 1268.
   PubMed Web of Science ®Google Scholar
• McSweeney, P, Wagner, J., Maloney, D., Radich, J., Shizuru, J., Bensinger, W., et al. (1998) "Outpatient PBSC allografts using immunosuppression with low dose TBI before and cyclo-sporine and mycophenolate mofetil after transplant", Blood 92, 519a.
   Web of Science ®Google Scholar
• McSweeney, P.A. and Storb, R. (1999) "Mixed chimerism: preclinical studies and clinical applications", Biol. Blood Marrow Transplant. 5(4), 192–203.
   PubMedGoogle Scholar
• Rondon, G., Giralt, S. and Huh, Y. (1996) "Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia", Bone Marrow Transplant. 18, 669–672.
   PubMed Web of Science ®Google Scholar
• Toze, C.L., Conneally, E.A., Connors, J.M., Nevill, T.J., Shepherd, J.D., Voss, N.J.S., et al. (2000) "Durable remission of follicular lymphoma after allogeneic bone marrow transplantation (BMT)", Blood 96(11), 358h.
   PubMed Web of Science ®Google Scholar
• Khouri, IF, Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., von Wolff, B., Gajewski, J., Donato, M., Claxton, D., Ueno, N., Andersson, B., Gee, A. and Champlin, R. (1998) "Tranplant-lite: induction of graft versus malignancy effect using fludarabine based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies", JCO, 2817–2824, Aug 1.
   Google Scholar
• Bader, P., Holle, W., Klingebiel, T., Handgretinger, R., Neithammer, D. and Beck, J. (1996) "Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT", Anticancer Res. 16(4A), 1759–1763.
   PubMed Web of Science ®Google Scholar
• Chakrabarti, S., Kottaridis, P., Ogormon, P., Peggs, K., Osman, H., Chopra, R., et al. (2000) "High incidence of early and late CMV infection and delayed immune constitution after allogeneic transplants with non-myeloablative con-ditioning using Campath (antiCD52 antibody)", Blood 96(11), 586a.
   Web of Science ®Google Scholar
• Carella, A.M., Cavaliere, M., Corsetti, M.T. and Lerma, E. (2000) "Allografting with immunosuppressive conditioning of low dose Fludarabine—cyclophosphamide after autograft-ing", Blood 96(11), 553a.
   Web of Science ®Google Scholar
• Slavin, S. (2000) "Treatment of myeloid leukemias with non-myeloablative stem cell transplantation: accomplishments and future goals", In: Schechter, G.P., ed, Hematology American Society of Hematology Education Program Book, pp 81–89.
   Google Scholar
• Robinson, SY., MacKinnon, S., Goldstone, A.H., Slavin, S., Carella, AM., Russell, N., et al. (2000) "Higher than expected transplant-related mortality following non-myeloablative transplantation for lymphoma adversely effect progression free survival", Blood 96(11), 554a.
   PubMed Web of Science ®Google Scholar
• Champlin, R., Khouri, I., Komblau, S., Molidrem, J. and Giralt, S. (1999) "Reinventing bone marrow transplantation: Nonmyeloablative preparative regimes and induction of graft-versus-malignancy effect", Oncology 13(5), 621–641.
   PubMed Web of Science ®Google Scholar
• Smit, W.M., Rijnbeek, M., van Bergen, C.A., Fibbe, W.E., Willemze, R. and Falkenburg, J.H. (1998) "T-cells recognizing leukemic CD34( + ) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation", Proc. Natl Acad. Sci. USA 95(17), 10152–10157.
   PubMed Web of Science ®Google Scholar
• Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C. and Bordignon, C. (1997) "HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia", Science 276(5319), 1719–1724.
   PubMed Web of Science ®Google Scholar
• Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E.J., Tisdale, J., Dunbar, C., Linehan, W.M., Young, N.S. and Barrett, A.J. (2000) "Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation", N. Engl. J. Med. 343(11), 750–758.
   PubMed Web of Science ®Google Scholar